HS
ETNB

HighVista Strategies’s 89bio ETNB Stock Holding History

HighVista Strategies’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-47,633
Closed -$468K – 158
2025
Q2 		$468K Buy
+47,633
New +$394K 0.17% 130
2024
Q4 		– Sell
-66,787
Closed -$494K – 152
2024
Q3 		$494K Buy
+66,787
New +$562K 0.17% 130
2023
Q4 		– Sell
-33,792
Closed -$522K – 132
2023
Q3 		$522K Sell
33,792
-9,847
-23% -$165K 0.24% 103
2023
Q2 		$827K Buy
+43,639
New +$766K 0.38% 63

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

HighVista Strategies's ETNB Position: Q3 2025 in Review

HighVista Strategies sold out of 89bio (ETNB) in Q3 2025, closing a stake of 47,633 shares — an estimated $468K sold.

HighVista Strategies first reported a position in ETNB in Q2 2023 and held it in 4 quarters. The position peaked at $827K in Q2 2023. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • HighVista Strategies reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
  • HighVista Strategies sold 47,633 89bio shares in Q3 2025, an estimated $468K.
  • HighVista Strategies first reported a position in 89bio in Q2 2023 and held it in 4 quarters.
  • HighVista Strategies's 89bio position peaked at $827K in Q2 2023.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on HighVista Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.